GGrantIndex
← Leaderboards

Michael A Tainsky

Wayne State University

Google Scholar ↗PubMed ↗ORCID ↗
$7,358,582
Attributed
$7,358,582
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2005–18
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$7,358,582 · 10

By mechanism

U01$3,299,208 · 1
R01$1,548,632 · 2
R33$1,374,486 · 1
R21$891,938 · 3
R03$154,000 · 1
P30$90,318 · 1

Top collaborators

No co-investigators on record.

Most similar at Wayne State University

Same institution · by research overlap

Others in their field

Top investigators on “Proteins”

Research focus

ProteinsCancer PatientTumorMalignant NeoplasmsTechnologyEarly DiagnosisScreening ProcedureSerumOncogenesBinding (Molecular Function)CohortSensitivity And SpecificityAntigensSamplingNeoplasm /Cancer GeneticsTranscription FactorLaboratoriesDiagnosticCharacteristicsDiagnostic TestsDetectionCell LineAntibodiesPhage Display

Grant awards (30)

Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families$77,000
R03 · FY2018 · CA · contact PI
Development of Cell-based Functional Tests for Rare Germline ATM Gene Variants in Hereditary Ovarian Cancer Families$77,000
R03 · FY2017 · CA · contact PI
Diagnostic Assays for OVCA Recurrence using Paraneoplastic Antigens and Epitopes$198,360
R21 · FY2015 · CA · contact PI
Diagnostic Assays for OVCA Recurrence using Paraneoplastic Antigens and Epitopes$165,300
R21 · FY2014 · CA · contact PI
Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer$296,476
R01 · FY2013 · CA · contact PI
Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer$315,400
R01 · FY2012 · CA · contact PI
Validation of an Antibody Test for Early Diagnosis of Ovarian Cancer$315,400
R01 · FY2011 · CA · contact PI
Serum Biomarkers for Colorectal Cancer Detection$165,419
R21 · FY2010 · CA · contact PI
Early Detection of Breast Cancer Using Autoantibody Mar*$702,169
U01 · FY2009 · CA · contact PI
Serum Biomarkers for Colorectal Cancer Detection$211,859
R21 · FY2009 · CA · contact PI
Molecular Biology and Human Genetics Program$22,446
P30 · FY2009 · CA · contact PI
Early Detection of Breast Cancer Using Autoantibody Mar*$703,194
U01 · FY2008 · CA · contact PI
Molecular Biology and Human Genetics Program$22,414
P30 · FY2008 · CA · contact PI
Early Detection of Breast Cancer Using Autoantibody Mar*$683,346
U01 · FY2007 · CA · contact PI
Markers for the Early Detection of Ovarian Cancer$467,514
R33 · FY2007 · CA · contact PI
Molecular Biology and Human Genetics Program$22,137
P30 · FY2007 · CA · contact PI
Early Detection of Breast Cancer Using Autoantibody Mar*$717,439
U01 · FY2006 · CA · contact PI
Markers for the Early Detection of Ovarian Cancer$474,996
R33 · FY2006 · CA · contact PI
Molecular Biology and Human Genetics Program$11,833
P30 · FY2006 · CA · contact PI
Early Detection of Breast Cancer Using Autoantibody Mar*$493,060
U01 · FY2005 · CA
Markers for the Early Detection of Ovarian Cancer$431,976
R33 · FY2005 · CA
Molecular Biology and Human Genetics Program$11,488
P30 · FY2005 · CA
Markers for the Early Detection of Ovarian Cancer$151,000
R21 · FY2003 · CA
DYSREGULATION OF DIFFERENTIATION IN RAS TRANSFORMED CELL$211,722
R01 · FY2002 · CA
MOLECULAR BIOLOGY AND GENETICS$0
P30 · FY2002 · CA
DYSREGULATION OF DIFFERENTIATION IN RAS TRANSFORMED CELL$207,074
R01 · FY2001 · CA
MOLECULAR BIOLOGY AND GENETICS$0
P30 · FY2001 · CA
MOLECULAR BIOLOGY AND GENETICS$0
P30 · FY2001 · CA
DYSREGULATION OF DIFFERENTIATION IN RAS TRANSFORMED CELL$202,560
R01 · FY2000 · CA
IN VITRO SCREENING OF CHEMOPREVENTIVE AGENTS$0
N01 · FY2000 · CN